The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

13 Jun 2012 07:00

RNS Number : 2299F
Sopheon PLC
13 June 2012
 



SOPHEON PLC

 

AGM Statement

 

At the Annual General Meeting of Sopheon plc to be held later today, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

 

"After strong growth in 2010, we reported 2011 revenues broadly similar to the prior year at £10.3m. EBITDA of £1.5m was also essentially the same as 2010, and in line with market expectations. Thanks to strict control of costs and enhanced conversion of development work into standard products, we achieved these results despite the expansion of staff in sales, services and development. For the second year in a row, we are also pleased to report a positive bottom-line profit after tax of £104,000.

 

Last year was characterized by strong demand from our client base for extension business, which absorbed the attention of our sales team. One consequence was that sales efforts were less focused on generating completely new accounts. We have now reorganized our sales resources to drive more balanced attention to both new account acquisition and generating additional growth out of our client base. We have already seen an improvement in new client acquisition compared to last year. We believe this will be reflected in improved license performance in 2012. In early 2011, we grew staff levels in key areas. These levels were maintained until recently, when increased demand led us to make further controlled expansion of staff. In particular, we advanced our market presence across Europe with the addition of two sales representatives. We also added technical resources across the business in response to growing service requirements. These hires were made with due caution given that global markets have not yet regained their poise.

 

During 2011, we introduced a new agile development methodology which has improved our ability to build products faster, and do a better job of ensuring that they are in step with real customer needs. A major product milestone was achieved with the release of Accolade 8.0, offering enhanced support for project portfolio management and collaboration, integration with Microsoft's SharePoint® and a mobile application for use with iPhone® and iPad® devices. We have also collaborated with Kalypso, the global innovation consulting firm and Sopheon partner, to introduce a new offering called FEI OptimizerTM that will help consumer goods manufacturers increase the value of new products by improving ideation and concept development.

 

On the corporate front, we successfully extended the maturity of the group's £850,000 convertible loan by two years to January 2015, coupled with a modification of the conversion price to 5p. In addition, we are today requesting shareholders to approve the transfer of Sopheon's listing from NYSE Euronext in Amsterdam to NYSE Alternext, an exciting market that is a better match for our corporate profile. This change is also subject to regulatory approval.

 

Full year 2012 revenue visibility from contracted business and recurring revenue streams has now risen to £7.5 million compared to £6.5 million announced on 3 May, and £6.6 million at the time of our AGM statement a year ago. We expect this to translate into higher reported first-half revenues than in 2011. In addition, we are working to close a substantial amount of business in the remaining weeks of June. Accurate prediction of the timing and value of sales events remains difficult, but if closed this month, the new business would further boost first-half performance." 

 

Sopheon's annual report and accounts for the year ended 31 December 2011 has been provided to shareholders and is available from the Company's website www.sopheon.com.

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte StrannerHenrik PerssonVictoria Bates

finnCap

+ 44 (0) 20 7600 1658

Guy McDougallHeather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) is an international provider of software and services. Sopheon's solutions structure, align and manage innovation processes to help organizations generate more revenues and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BAE Systems, BASF, Corning, Electrolux, Honeywell, Novartis and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com. 

 

Revenue visibility is defined in Note4 of Sopheon's 2011 annual report which is available from the investor section of www.sopheon.com .

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFLRRTIFLIF
Date   Source Headline
3rd Nov 202310:15 amRNSForm 8.5 (EPT/NON-RI)
3rd Nov 20238:54 amRNSForm 8.3 - Rivomore Limited - Sopheon plc
2nd Nov 20239:34 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20233:44 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
1st Nov 20231:55 pmRNSForm 8.3 - Sopheon plc
1st Nov 202311:23 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 202310:51 amGNWForm 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
1st Nov 202310:35 amRNSForm 8.3 - Sopheon PLC
31st Oct 20231:00 pmRNSStatement re Possible Offer
24th Aug 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSAcquisition
15th Jun 20235:06 pmRNSIssue of Equity
8th Jun 20231:35 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
13th Apr 20234:20 pmRNSIssue of Equity
31st Mar 20239:14 amRNSIssue of Equity
27th Mar 20234:23 pmRNSDirector Shareholdings
24th Mar 20237:00 amRNSDirector Share Purchases
23rd Mar 20237:00 amRNSFinal Results
22nd Feb 20234:59 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDirectorate Change and Notice of Results
30th Jan 20237:00 amRNSTrading Update
20th Sep 202212:01 pmRNSSopheon launches Acclaim Line of SaaS Offerings
2nd Sep 202210:06 amRNSIssue of Equity
1st Sep 20227:00 amRNSNew Release of Award-winning Innovation Product
24th Aug 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSFive-year, $11.2m Enterprise Agreement
3rd Aug 202210:18 amRNSHolding(s) in Company
21st Jun 202212:20 pmRNSHolding(s) in Company
9th Jun 20222:30 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
6th Jun 20226:02 pmRNSIssue of Equity & TVR
23rd May 20227:00 amRNSDirector Dealing & Issue of Equity
18th May 20227:00 amRNSAcquisition
29th Apr 20225:12 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSNew Sopheon Software Release
1st Apr 202212:10 pmRNSDirector Shareholdings
24th Mar 20227:00 amRNSFinal Results
25th Jan 20227:00 amRNSTrading Update
17th Jan 20223:15 pmRNSIssue of Equity
20th Dec 20217:00 amRNSAcquisition and Trading Update
24th Sep 20211:52 pmRNSIssue of Equity
16th Sep 202110:00 amRNSHolding(s) in Company
13th Sep 20215:24 pmRNSIssue of Equity
31st Aug 20216:14 pmRNSDirector Shareholdings
25th Aug 20217:00 amRNSInterim Results
13th Jul 20217:00 amRNSNew Release Drives Business Transformation
23rd Jun 20217:00 amRNSSopheon Earns Authority to Operate for NAVSEA
15th Jun 20219:54 amRNSIssue of Equity
10th Jun 202111:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.